Efficacy and Safety of Necitumumab and Pembrolizumab Combination Therapy in Stage IV Nonsquamous Non-Small Cell Lung Cancer (NSCLC)

被引：4
|
作者：
Besse, Benjamin [1 ]
Garrido, Pilar [2 ]
Puente, Javier [3 ]
Cortot, Alexis [4 ]
Eugenia Olmedo, Maria [2 ]
Perol, Maurice [5 ]
Gil, Maciej [6 ]
Chao, Grace [7 ]
Shahidi, Javad [8 ]
Bennouna, Jaafar [9 ]
机构：
[1] Gustave Roussy, Dept Canc Med, Villejuif, France
[2] Hosp Univ Ramon Y Cajal, Med Oncol Dept, Madrid, Spain
[3] Hosp Clin San Carlos, Med Oncol Dept, Madrid, Spain
[4] Lille Univ Hosp, Thorac Oncol, Lille, France
[5] Ctr Leon Berard, Grp Thorac & Orl, Lyon, France
[6] Eli Lilly, Warsaw, Poland
[7] Eli Lilly & Co, Bridgewater, MA USA
[8] Eli Lilly & Co Bridgewater, Bridgewater, MA USA
[9] Inst Cancerol LOuest, Nantes, France
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
non-small cell lung cancer; Necitumumab; pembrolizumab;
D O I：
10.1016/j.jtho.2016.11.451
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA09.11
引用
收藏
页码：S397 / S397
页数：1
相关论文
共 50 条
  • [11] Necitumumab for non-small cell lung cancer
    Greillier, Laurent
    Tomasini, Pascale
    Bariesi, Fabrice
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (08) : 1231 - 1239
  • [12] Neoadjuvant Pembrolizumab in Early Stage Non-Small Cell Lung Cancer (NSCLC): Toxicity, Efficacy, and Surgical Outcomes
    Ready, N.
    Tong, B.
    Clarke, J.
    Gu, L.
    Wigle, D.
    Dragnev, K.
    Sporn, T.
    Stinchcombe, T.
    D'Amico, T.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S745 - S745
  • [13] SPIROMETRY IN PATIENTS WITH STAGE IV NON-SMALL CELL LUNG CANCER (NSCLC)
    Mendis, R.
    McDonald, C. F.
    John, T.
    O'Donoghue, F. J.
    White, S. C.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S75 - S75
  • [14] A phase 1b study of necitumumab in combination with abemaciclib in patients with stage IV non-small cell lung cancer
    Besse, B.
    Barlesi, F.
    Demedts, I.
    Fuentes Pradera, J.
    Renault, A.
    Robinet, G.
    Frimodt-Moller, B.
    Gil, M.
    Vansteenkiste, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S76 - S76
  • [15] A phase 1b study of necitumumab in combination with abemaciclib in patients with stage IV non-small cell lung cancer
    Besse, Benjamin
    Barlesi, Fabrice
    Demedts, Ingel
    Pradera, Jose Fuentes
    Robinet, Gilles
    Gazzah, Anas
    Soldatenkova, Victoria
    Frimodt-Moller, Bente
    Kim, Jong Seok
    Vansteenkiste, Johan
    LUNG CANCER, 2019, 137 : 136 - 143
  • [16] Therapy for stage IIIB and stage IV non-small cell lung cancer
    Kim, TE
    Murren, JR
    CLINICS IN CHEST MEDICINE, 2002, 23 (01) : 209 - +
  • [17] Efficacy and Safety of Necitumumab Continuation Therapy in the Phase III SQUIRE Study of Patients With Stage IV Squamous Non-Small-Cell Lung Cancer
    Ciuleanu, Tudor
    Socinski, Mark A.
    Obasaju, Coleman
    Luft, Alexander V.
    Szczesna, Aleksandra
    Szafranski, Wojciech
    Ramlau, Rodryg
    Balint, Beatrix
    Molinier, Olivier
    Depenbrock, Henrik
    Nanda, Shivani
    Paz-Ares, Luis
    Thatcher, Nick
    CLINICAL LUNG CANCER, 2018, 19 (02) : 130 - +
  • [18] Efficacy and safety of bevacizumab in nonsquamous non-small cell lung cancer with brain metastases.
    Ichiki, Masao
    Yoshida, Tsukasa
    Nakamura, Masayuki
    Kumano, Tomomi
    Hoshino, Tomoaki
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [19] Pooled analysis of venous thromboembolism (VTE) from four trials of necitumumab and chemotherapy for stage IV non-small cell lung cancer (NSCLC).
    Young, Kelvin
    Paz-Ares, Luis G.
    Thatcher, Nick
    Spigel, David R.
    Shahidi, Javad
    Soldatenkova, Victoria
    Grau, Gerrit
    Kurek, Raffael
    Shepherd, Frances A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [20] Maintenance chemotherapy after frontline therapy in patients with nonsquamous non-small cell lung cancer (NSCLC)
    Santos, E. S.
    Belalcazar, A.
    Gomez, J. E.
    Ochoa, R. E.
    Karr, M.
    Raez, L. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345